Search
for
Sort by
Research 751–780 of 1000+
- How do You Treat Alopecia in Your Clinic?
- Eczémas de contact atypiques ou sévères à l’huile essentielle de cannelle
- What's New: Newly Approved Drugs for Children
- WHAT OTHER JOURNALS ARE SAYING
- Allergic contact dermatitis to Minoxidil
- Cocaine-related bullous disease
- Scalp Psoriasiform Contact Dermatitis with Acute Telogen Effluvium due to Topical Minoxidil Treatment
- Allergic contact dermatitis from minoxidil
- Allergic contact dermatitis to topical brimonidine
- Pinnal Diseases
- “Prick or treat”: a case of systemic reaction during intradermal tests with beta-lactams
- An unusual eyelid swelling
- 14 Dermatological drugs, topical agents, and cosmetics
- Dermatological drugs, topical agents, and cosmetics
- Food allergies
- Trends in dermatological presentations at the emergency department of a tertiary hospital in Singapore: a 4-year analysis pre- and during COVID-19
- Farmácia Beleza, Matosinhos e Serviços Farmacêuticos do Cittadella Hospital - ULSS 6 Euganea, Itália
- IN OTHER JOURNALS
- Botulinum toxin: Pearls & pitfalls
- FC‐12 Diagnostic value of skin biopsy in feline symmetric alopecia
- Dermatological drugs and topical agents
- Announcements
- Hair loss.
- Contact sensitization to hair care allergens in scalp seborrheic dermatitis: associations with disease severity and microbiota profiles
- Cicatricial alopecia of the scalp as a manifestation of IgG4-related disease mimicking acne keloidalis nuchae
- Real-life effectiveness and safety of baricitinib in 17 Japanese patients with alopecia areata: a 60-week single center study
- A case of sarcoidal foreign body reaction to permanent makeup: the involvement of M2 macrophages
- Evaluation of Serum Homocysteine, High-Sensitivity CRP, and RBC Folate in Patients with Alopecia Areata
- Hypersensitivity reactions to anticoagulant drugs: diagnosis and management options
- Scalp biomarkers during dupilumab treatment support Th2 pathway pathogenicity in alopecia areata